483 Hikma Pharmaceuticals USA Mar 2009

483 Hikma Pharmaceuticals USA Mar 2009

Paul Bellamy FDA, Devon Jenkins FDA, Krystyna Kitson FDA$119.00 - Available Now

FDA investigators audited the Hikma Pharmaceuticals USA - Cherry Hill, NJ, United States facility and issued 1 inspectional observation (via FDA 483) on 10 Mar 2009.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 10 Mar 2009
  • Location: Cherry Hill, United States
  • FEI: 2220525
Add To Cart